Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of the treatment of the disease require individualized management, typically including drug therapy, cosmetic surgery, regular follow-up, etc.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment processes require close monitoring of therapeutic effects and adverse reactions, adapting timely to changes in disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the screening of newborns with primary carcinoma deficiency.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.